On Friday, Health Canada authorized the Pfizer vaccine for children, making it the first in the country to receive regulatory approval for that age group. A total of 2.9 million doses are expected arrive by the end of next week.
"So at the end of the day, either from a NACI standpoint or for any … provincial jurisdictions, it remains their decisions to apply the immunization programs the way they feel is most appropriate for their population."Paquette said through discussions with federal authorities, particularly the U.S. Food and Drug Administration , a three-week interval was agreed upon for Pfizer's clinical programs, as was the case for adolescents and adults.
"Now, we can make some assumptions based on what we've seen in the … adult groups, and that's probably the way the analysis has been done by the public health authorities. But related to what we see right now, the data available are really with an interval of three weeks." He said Pfizer submitted a "significant" amount of data to Health Canada, namely for the Phase 2 and 3 trials, with more than 4,600 children participating, resulting in 91 per cent effectiveness and few side effects.
Source: Healthcare Press (healthcarepress.net)
What's wrong with you
Which showed to be a wise strategy with adults.